ERA4TB

📣 ERA4TB webinar alert!

🕒 Only one day left!

ERA4TB, in collaboration with @NICEComms and the @WHO, are proud to introduce our speakers for tomorrow's webinar!

Register to save your spot: tinyurl.com/ERA4TB

📣 ERA4TB webinar alert!

🕒 Only two days left! Do not miss our online webinar, focusing on tackling anti-microbial resistance through policy and partnerships

Register here: tinyurl.com/ERA4TB

The team presented to general audience members, the #HollowFibreSystem. They explained how this innovative piece of technology, is supporting research in drug development.

Well done to those involved!

On Friday 26th September 2025, #ERA4TB Consortium members from @unizar.es and Università di Padova participated at the European Researchers' Night (2025) celebrations in Zaragoza, Spain.

📣 ERA4TB Webinar Announcement!

One week left to register for our webinar on 'Innovating Access: Tackling Anti-Microbial Resistance Through Policy'.

📅 Date: 8 October 2025; 1-2pm UK time
💻 Register here: tinyurl.com/ERA4TB

After a fun round of memory games, contestants were awarded with stickers, featuring the ERA4TB logo.

Well done Deborah Recchia, Maria Rosalia Pasca and the rest of our colleagues on creating such a fun and interactive experience!

The team created a poster, featuring Alessandro Stamilla in cartoon form. Using terminology tailored for a younger audience, the poster explained what the ERA4TB project is and its goal for defeating Tuberculosis (TB).

Some exciting news!

#ERA4TB Consortium Members from University of Pavia, hosted an interactive stand at Sharper Night - European Researchers' Night (2025).

Video Conferencing, Web Conferencing, Webinars, Screen Sharing Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom ...

ERA4TB Webinar 📣

How can health systems respond to #AMR through innovation & evidence-based policy? 🌍✨

🗓️ 8 Oct 2025 | 1–2pm UK | 2–3pm CEST
🎙️ Speakers from NICE & WHO

👉 Register: tinyurl.com/ERA4TB

@amr-accelerator.bsky.social @amr-accelerator.bsky.social @tballiance.bsky.social

The other poster looked at Investigating Bedaquiline Mechanisms of Action and Resistance: A Focus on MmpL4/MmpL5 Siderophore Transporters and the Novel Diarylquinoline TBAJ-587

If you would like to know more about Deborah’s work with EUCAST or TBAJ-587, please reach out to us.

ERA4TB Webinar 📣

How can health systems respond to #AMR through innovation & evidence-based policy? 🌍

Join our ERA4TB webinar

🗓️ 8 Oct 2025 | 1–2pm UK | 2–3pm CEST
🎙️ Speakers from @NICEComms & @WHO

👉 Register: tinyurl.com/ERA4TB

@amr-accelerator.bsky.social @who.int @nicecomms.bsky.social

More #ERA4TB partners SIMGM Congress - Microbiology 2025!

Deborah Recchia (University of Pavia) showcased two of her posters at SIMGM Congress.

The first poster, focused on the optimization of European Committee on Antimicrobial Susceptibility Testing (EUCAST).

An image of Santiago Ramon Garcia, presenting at SIMGBM Congress - Microbiology 2025.

Santiago Ramon Garcia (UNIZAR), gave a presentation on ‘Optimized in-vitro tools to inform pre-clinical and clinical progression of Tuberculosis combination therapy’. The presentation was well received by attendees. Well done, Santiago!

ERA4TB consortium members standing outside the venue for SIMGBM Congress - Microbology 2025.

Last week, #ERA4TB Consortium members from @unizar.es, Università di Pavia and Università di Padova attended the SIMGBM Congress - Microbiology 2025 in Rome.

@era4tb.bsky.social researchers found compounds that block TB’s ESX-1 system (used to damage immune cells) while also improving effectiveness of ethionamide. A dual-action step against drug-resistant TB.

👉 𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲: bit.ly/3VJJJBw

Eik Hoffman (@pasteurlille.bsky.social ), presented at #IUSI2025 in Vienna, Austria on behalf of #ERA4TB. He discussed the host-pathogen interaction (HPI) platform (BT08) and work of partners from ERA4TB: UHC, @unizar.es, FZB, UNIPD, UPV, @uc3m.es and @cnrs.fr. Contact Eik to find out more!

Last week, we got together to focus on a key part of TB research: advancing animal models. Six ERA4TB experts discussed how ethical animal models can drive better treatments for drug-resistant TB and speed up testing of new therapies. While the webinar was internal, the impact is global.

@ihieurope.bsky.social @amr-accelerator.bsky.social

An image of Santiago Ramon, standing in front of his poster at the Gordon Research Conference.

This week at #GordonResearchConference, Santiago Ramon (@unizar.es) presented his poster on how #ERA4TB has built a multi-institutional and multidisciplinary network of more than 150 highly qualified and perfectly coordinated scientists to advance new TB drugs #TBpipeline #TranslationalResearch

I was taking 23 pills every day for 10 months.” A TB survivor shared this at ERA4TB’s MDR-TB dialogue. Behind every protocol is a person. That’s why we say “people affected by TB” or “TB survivors”. Language shifts power, from object to partner. Research must listen and build with communities.

Ainhoa Quintana (@unizar.es), presented at #GordonResearchConference today, on behalf of #ERA4TB consortium. She showcased the important role that ERA4TB's #InVitroModels play in our translational framework to advance TB drug candidates through the pipeline. Contact Ainhoa to find out more!

These tools are highly standardized across ERA4TB partners, ensuring the generation of robust, comparable data to support the progression of promising drug candidates. 2/2

His work highlights how viability assays and molecular biomarkers are used as complementary tools to inform and strengthen the translational framework within ERA4TB. 1/2

Juan Calvet (@uc3m.es) presented a poster on the integration of molecular biomarkers into time-kill assays for evaluating new anti-TB drug candidates.

@amr-accelerator.bsky.social
@ihieurope.bsky.social
#Tuberculosis #TB #TranslationalResearch #Biomarkers #TimeKillAssays

We're at the Gordon Research Conference on Tuberculosis Drug Discovery and Development. Come talk to us!

#ERA4TB #TB #TranslationalResearch #DrugDevelopment

Diana Aguilar from @unizar.es presented at #ASMMicrobe on June 22, on behalf of the ERA4TB consortium.
Diana shared how ERA4TB has built a robust translational platform to accelerate the progression of anti-TB drug candidates and combinatorial regimens.

#TBSky #TBResearch #DrugDevelopment

Lara V from ERA4TB partner @uc3m.es is attending the 38th IEEE International Symposium on Computer-Based Medical Systems, held in Madrid. Lara was presenting on ‘Detection of active and latent tuberculosis with explainable deep learning ensembles’ along with her colleagues.

#TBSky #TBResearch

Good luck to all the ERA4TB consortium members presenting at PAGE 2025 this week.

www.page-meeting.org/default.asp?...

#TBSky #TBResearch #Tuberculosis

Some highlights from our incredible ERA4TB 9th Consortium Meeting last week!

🔬Keynotes on antimicrobial resistance & new TB medicine development
💊Progress on TBAJ-587
🔍Novel drug testing approaches & mechanisms of action

@ihieurope.bsky.social @amr-accelerator.bsky.social @www.unizar.es

📅 3rd June 2025

Lindsay Sonnenkalb from @fzborstel.bsky.social will be speaking on ‘New technologies for understanding drug resistance’. 25 minute slots will be available throughout the day.

➡️Book here: www.leibniz-gemeinschaft.de/ueber-uns/ne...

#Tuberculosis #TBResearch #TBSky